Nyxoah SA (NYXH)

NASD · Healthcare · Medical Devices · Belgium

Nyxoah SA is a micro cap company (market value under $300 million) in the Medical Devices industry.

Intrinsic value, DCF valuation, financial health and value investing analysis for the Nyxoah SA stock.

Our verdict on NYXH

Overvalued: intrinsic value $0.54 per share, market price $0.90, margin of safety -67.1% (as of 2026-11-17).

A 0.9x revenue multiple, discounted for its losses, values the shares at $0.54; the price of $0.90 is 67% above that value.

More on NYXH

Peers in Medical Devices

All 140 Medical Devices stocks

Cheaper than NYXH in Medical Devices

34 more in this industry show a wider margin of safety.

Is NYXH undervalued or overvalued?

NYXH is overvalued (as of the 2026-11-17 close). A 0.9x revenue multiple, discounted for its losses, values the shares at $0.54; the price of $0.90 is 67% above that value.

What is the intrinsic value of NYXH?

$0.54 per share (as of the 2026-11-17 close), against a market price of $0.90. That is a margin of safety of -67.1%. The value comes from the one valuation method that applies to this company, recomputed every night after the US close.